HEMANEXT INC.

99 Hayden Ave Ste 620, Lexington, Massachusetts, United States

Also known as:

hemanext

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

40.0%

Phase 2

40.0%

Trial Status Distribution

Active, not recruiting

20.0%

Completed

40.0%

Not yet recruiting

20.0%

Withdrawn

20.0%

Clinical Trials

Trials sponsored by this organization (5)

Hypoxic Red Blood Cells in Sickle Cell Anemia

Not Applicable

Not yet recruiting

interventional

Sep 202648 participants

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

Not Applicable

Active, not recruiting

interventional

Nov 202424 participants

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

Completed

observational

Aug 202222 participants

Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells

Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial

Phase 2

Completed

interventional

Nov 2017100 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations